首页> 美国卫生研究院文献>Drug Design Development and Therapy >Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimers Disease: Synthesis Characterization Computational and in vitro Approaches
【2h】

Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimers Disease: Synthesis Characterization Computational and in vitro Approaches

机译:两种新的吡啶基锌(II)酰胺羧酸盐在Alzheimer疾病中的前瞻性应用:合成表征计算和体外方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Alzheimer’s disease (AD) is a neurodegenerative illness described predominantly by dementia. Even though Alzheimer’s disease has been known for over a century, its origin remains a mystery, and researchers are exploring many therapy options, including the cholinesterase technique. A decreased acetylcholine ACh neurotransmitter level is believed to be among the important factors in the progression of Alzheimer’s disease.
机译:阿尔茨海默病(AD)是一种神经变性疾病,主要由痴呆症描述。尽管阿尔茨海默氏病过超过一个世纪的疾病,但它的起源仍然是一个谜,研究人员正在探索许多治疗选择,包括胆碱酯酶技术。乙酰胆碱Ach神经递质水平降低是阿尔茨海默病进展的重要因素之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号